Description of impact
Work on cost analysis of shorter vs longer repeat prescriptions picked up by NHS England who are considering updating their policy on longer repeat Rxs as a result.Who is affected
All patients with a stable, chronic disease requiring regular repeat prescriptionsNarrative
Email from Peter Liu, Senior Policy Manager, Primary Care Strategy and Contracts team, NHS England who had read the paper and had some queries before presenting a case to NHS England to recommend 3 month rather than 1 month repreat Rx durations unless otherwise clinically indicated. Presentation is 4/11/2020. My work was the key evidence used to inform this proposed policy change.| Impact status | Open |
|---|---|
| Category of impact | Public policy Impacts |
| Impact level | Adoption |
Related content
-
Research output
-
Retrospective, multicohort analysis of the Clinical Practice Research Datalink (CPRD) to determine differences in the cost of medication wastage, dispensing fees and prescriber time of issuing either short (<60 days) or long (≥60 days) prescription lengths in primary care for common, chronic conditions in the UK
Research output: Contribution to journal › Article › peer-review